Evidence map›Paper›PMID 32302442›Full record

ArticleJournal of thrombosis and haemostasis : JTH2020

RE: ISTH interim guidance to recognition and management of coagulopathy in COVID-19.

Satoshi Akima, Claire McLintock, Beverley J Hunt

Registry-linked trialAbstract readLetterComment
In one paragraph

Article in Journal of thrombosis and haemostasis : JTH, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04420312 (Incidence and Characteristics of Pulmonary Embolism in COVID-19 Patients Hospitalized for Acute Respiratory Syndrome), which is not on this map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04420312 completednot on this map

Incidence and Characteristics of Pulmonary Embolism in COVID-19 Patients Hospitalized for Acute Respiratory Syndrome

TypeobservationalSponsorFondation Hôpital Saint-JosephRan2020 to 2020Enrolled1,024ConditionsPulmonary Embolism, Covid-19
3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. D-dimer testing in clinical practice in the era of COVID-19.Research and practice in thrombosis and haemostasis · 2022
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Risk Management and Treatment of Coagulation Disorders Related to COVID-19 Infection.International journal of environmental research and public health · 2021
    Review
  15. Anticoagulation in COVID-19: a single-center retrospective study.Journal of community hospital internal medicine perspectives · 2021
    Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Satoshi AkimaDepartment of General Medicine, Campbelltown Hospital, Campbelltown, NSW, Australia.
Claire McLintockHaematologist and Obstetric Physician, National Women's Health, Auckland City Hospital, New Zealand.ORCID 0000-0002-4771-8760
Beverley J HuntThrombosis & Haemostasis, King's College, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BetacoronavirusBlood Coagulation DisordersCoronavirus InfectionsPandemicsPneumonia, ViralCOVID-19HumansSARS-CoV-2

Identifiers

PMID32302442
PMCPMC9770917

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.